An interview with Oramed Pharmaceuticals CEO and Principal Investigator about a Phase 2b study of its oral insulin and the latest clinical results.
Read More »Yearly Archives: 2019
Diabetes Risks Using Glucocorticoids
Glucocorticoids (GC) may expose patients to the risk of diabetes, particularly with long term use.
Read More »The First Automated Insulin Dosing Controller FDA Approved
This approval is an example of artificial intelligence being used to improve the health of our patients with diabetes and will get us closer to a true artificial pancreas.
Read More »HbA1c Minimally Adds to CVD Risk Prediction in Prediabetes
Classical risk factors explain most of the increased risk for CVD associated with HbA1c in prediabetes
Read More »Vitamin D Supplementation Alone May Not Reduce Fracture Risk
However, meta-analysis shows significant reduction in any, hip fracture with vitamin D plus calcium
Read More »Congress Approves Raising Age to Buy Tobacco Products to 21
Measure was supported by many tobacco and electronic cigarette companies
Read More »T2DM Risk Cut With Weight Loss Even in Nonoverweight People
Findings seen even among nonoverweight, regardless of family diabetes history, genetic risk for T2DM
Read More »Refined Carbs May Up Insomnia Risk in Postmenopausal Women
Highly processed foods containing large amounts of refined sugars may be a dietary culprit for insomnia
Read More »Congress Could Raise Age to Buy Tobacco Products to 21
19 states and the District of Columbia have already increased the age to buy tobacco products to 21
Read More »Dec. 17, 2019
The FDA gave approval to Tandem’s Control IQ this past week and the word is on the streets already. My wife was at the endo office today and he was telling her about it, and told her it would improve her 6.1 A1c. He also mentioned that he may have …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.